2010
DOI: 10.3109/13697130903296909
|View full text |Cite
|
Sign up to set email alerts
|

Obesity, metabolic complications and the menopause: an opportunity for prevention

Abstract: The prevalence of obesity is rising dramatically, impacting adversely on health and well-being at the menopause and across the lifespan. With menopause, abdominal adiposity selectively increases. The impact of obesity and abdominal adiposity on chronic disease, including diabetes and cardiovascular disease, is significant and quality of life is adversely affected. Yet accurate perception of the weight-related health-risk profile is lacking and there is inadequate focus on prevention and treatment of obesity an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
33
0
2

Year Published

2012
2012
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 65 publications
(36 citation statements)
references
References 44 publications
1
33
0
2
Order By: Relevance
“…In the current study, to investigate hormonal effects, a large population of women was divided by menopausal profile, which was considered to be a critical contributing factor in determining hormonal differences in women. Our finding was consistent with previous studies [16,17,18], which reported an increased trend in the prevalence of obesity after menopause. It is possible that the findings are associated with changes in reproductive hormones, such as estrogen, follicle stimulating hormone (FSH), and luteinizing hormone (LH) as well as melatonin secretion after entering menopause [15,16].…”
Section: Discussionsupporting
confidence: 94%
“…In the current study, to investigate hormonal effects, a large population of women was divided by menopausal profile, which was considered to be a critical contributing factor in determining hormonal differences in women. Our finding was consistent with previous studies [16,17,18], which reported an increased trend in the prevalence of obesity after menopause. It is possible that the findings are associated with changes in reproductive hormones, such as estrogen, follicle stimulating hormone (FSH), and luteinizing hormone (LH) as well as melatonin secretion after entering menopause [15,16].…”
Section: Discussionsupporting
confidence: 94%
“…The incidence of metabolic alteration including the development of insulin resistance increases substantially during menopause [28]. In our study, female subjects in the menstrual stage had significantly lower mean ferritin levels than menopausal females.…”
Section: Discussionmentioning
confidence: 71%
“…[1] MetS has emerged as an underlying risk factor for a wide variety of diseases[4,8,14] and most postmenopausal women exhibit three or more MetS components. [24] Several factors can contribute to the increased prevalence of MetS in postmenopausal women, including age, reduced physical activity and energy expenditure,[20,35] increased caloric intake,[23] variation in hormonal patterns,[33] and attitude and perception relative to weight and weight management after menopause. These risk factors for MetS are of considerable importance to middle-aged and older women’s health, due to the fact that MetS components increase through the transition period from pre- to post menopause which, in turn, might explain the increased incidence and prevalence of diseases and comorbidities in women after menopause.…”
Section: Introductionmentioning
confidence: 99%